QL inhibits the TGF-β1/Smad3 signaling pathway through up-regulation of miR-133a and miR-345-3p, thereby attenuating myocardial fibrosis and improving cardiac function (255, 256). The gene discussed is SMAD3; the disease is Myocardial fibrosis.